High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).

被引：0
|
作者：
Srour, Samer Ali [1 ]
Khouri, Issa F. [1 ]
Nieto, Yago [1 ]
Popat, Uday R. [1 ]
Qazilbash, Muzaffar H. [1 ]
Anderlini, Paolo [1 ]
Kebriaei, Partow [1 ]
Shpall, Elizabeth J. [1 ]
Champlin, Richard E. [1 ]
Hosing, Chitra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HIGH-DOSE VERSUS STANDARD-DOSE RITUXIMAB WITH BEAM IN AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR RELAPSED AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMAS (NHL)
    Srour, S. A.
    Lozano, S.
    Nieto, Y.
    Alousi, A. M.
    Popat, U. R.
    Quazilbash, M. H.
    Anderlini, P.
    Kebriaei, P.
    Shpall, E.
    Champlin, R. E.
    Hosing, C.
    HAEMATOLOGICA, 2016, 101 : 114 - 114
  • [2] A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results
    Srour, Samer A.
    Li, Shaoying
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Lozano-Cerrada, Sara
    Maadani, Farzeneh
    Alousi, Amin
    Kebriaei, Partow
    Anderlini, Paolo
    Nieto, Yago
    Jones, Roy
    Shpall, Elizabeth
    Champlin, Richard E.
    Hosing, Chitra
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (04) : 561 - 570
  • [3] Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
    Khouri, IF
    Saliba, RM
    Hosing, C
    Okoroji, GJ
    Acholonu, S
    Anderlini, P
    Couriel, D
    De Lima, M
    Donato, ML
    Fayad, L
    Giralt, S
    Jones, R
    Korbling, M
    Maadani, F
    Manning, JT
    Pro, B
    Shpall, E
    Younes, A
    McLaughlin, P
    Champlin, RE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2240 - 2247
  • [4] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma
    Kriegsmann, Katharina
    Rieger, Michael
    Schwarzbich, Mark-Alexander
    Sitter, Soeren
    Kriegsmann, Mark
    Bruckner, Thomas
    Hensel, Manfred
    Ho, Anthony Dick
    Witzens-Harig, Mathias
    Wuchter, Patrick
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 12 - 20
  • [5] High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma
    Verdonck, LF
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3003 - 3003
  • [6] High-dose therapy and stem cell transplantation (BMT) for relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Shahidi, H
    Gregory, SA
    GuptaBurt, S
    Adler, SS
    Venugopal, P
    Meyer, P
    Korenblit, AD
    Recine, D
    Manson, S
    Kaizer, H
    BLOOD, 1997, 90 (10) : 1023 - 1023
  • [7] Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
    Horwitz, SM
    Negrin, RS
    Blume, KG
    Breslin, S
    Stuart, MJ
    Stockerl-Goldstein, KE
    Johnston, LJ
    Wong, RM
    Shizuru, JA
    Horning, SJ
    BLOOD, 2004, 103 (03) : 777 - 783
  • [8] Improved outcome with high-dose rituximab (HD-R) with G/GM-CSF and autologous stem cell transplantation (ASCT) for relapsed aggressive B-cell non-Hodgkin's lymphomas (NHL): The impact of histologies of follicular (FL) origin.
    Khouri, IF
    Saliba, RM
    Acholonu, S
    Okoroji, GJ
    Hosing, C
    Fayad, L
    Couriel, DR
    Pro, B
    Giralt, S
    Andersson, B
    Younes, A
    McLaughlin, P
    Champlin, RE
    BLOOD, 2003, 102 (11) : 735A - 736A
  • [9] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [10] Rituximab for aggressive non-Hodgkin's lymphomas relapsing or refractory to autologous stem cell transplantation
    Pan, D
    Moskowitz, CH
    Zelenetz, AD
    Straus, D
    Kewalaramani, T
    Noy, A
    Qin, J
    Teruya-Feldstein, J
    Portlock, CS
    CANCER JOURNAL, 2002, 8 (05): : 371 - 376
12345